aluates Reports

$ 0.0

Automative

Global Oncolytic Virus Drug Treatment Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-21T10801

Global Oncolytic Virus Drug Treatment Market Research Report 2022

BUY CHAPTERS

Global Oncolytic Virus Drug Treatment Market Research Report 2025

Code: QYRE-Auto-21T10801

Report

February 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Amgen Inc

Oncolytics Biotech

Viralytics

Transgene SA

Oncolys BioPharma

Targovax

PsiOxus Therapeutics

SillaJen Biotherapeutics

Sorrento Therapeutics

Lokon Pharma

Genelux Corporation

Vyriad

TILT Biotherapeutics

Cold Genesys

Oncolytic Virus Drug Treatment Market Size

The global market for Oncolytic Virus Drug Treatment was valued at US$ 9 million in the year 2024 and is projected to reach a revised size of US$ 41.8 million by 2031, growing at a CAGR of 24.9% during the forecast period.

Oncolytic Virus Drug Treatment Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Drug Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Drug Treatment.

The Oncolytic Virus Drug Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncolytic Virus Drug Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oncolytic Virus Drug Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oncolytic Virus Drug Treatment Market Report

Report Metric	Details
Report Name	Oncolytic Virus Drug Treatment Market
Accounted market size in year	US$ 9 million
Forecasted market size in 2031	US$ 41.8 million
CAGR	24.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Phase 1 Phase 2 Others
Segment by Application	Melanoma Prostate Cancer Breast Cancer Ovarian Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics, Cold Genesys
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncolytic Virus Drug Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oncolytic Virus Drug Treatment Market growing?

Ans: The Oncolytic Virus Drug Treatment Market witnessing a CAGR of 24.9% during the forecast period 2025-2031.

What is the Oncolytic Virus Drug Treatment Market size in 2031?

Ans: The Oncolytic Virus Drug Treatment Market size in 2031 will be US$ 41.8 million.

Who are the main players in the Oncolytic Virus Drug Treatment Market report?

Ans: The main players in the Oncolytic Virus Drug Treatment Market are Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics, Cold Genesys

What are the Application segmentation covered in the Oncolytic Virus Drug Treatment Market report?

Ans: The Applications covered in the Oncolytic Virus Drug Treatment Market report are Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Others

What are the Type segmentation covered in the Oncolytic Virus Drug Treatment Market report?

Ans: The Types covered in the Oncolytic Virus Drug Treatment Market report are Phase 1, Phase 2, Others

Recommended Reports

Cancer Therapeutics

Virus & Antiviral Drugs

Oncology Diagnostics & Devices

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oncolytic Virus Drug Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Phase 1

1.2.3 Phase 2

1.2.4 Others

1.3 Market by Application

1.3.1 Global Oncolytic Virus Drug Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Melanoma

1.3.3 Prostate Cancer

1.3.4 Breast Cancer

1.3.5 Ovarian Cancer

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oncolytic Virus Drug Treatment Market Perspective (2020-2031)

2.2 Global Oncolytic Virus Drug Treatment Growth Trends by Region

2.2.1 Global Oncolytic Virus Drug Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oncolytic Virus Drug Treatment Historic Market Size by Region (2020-2025)

2.2.3 Oncolytic Virus Drug Treatment Forecasted Market Size by Region (2026-2031)

2.3 Oncolytic Virus Drug Treatment Market Dynamics

2.3.1 Oncolytic Virus Drug Treatment Industry Trends

2.3.2 Oncolytic Virus Drug Treatment Market Drivers

2.3.3 Oncolytic Virus Drug Treatment Market Challenges

2.3.4 Oncolytic Virus Drug Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oncolytic Virus Drug Treatment Players by Revenue

3.1.1 Global Top Oncolytic Virus Drug Treatment Players by Revenue (2020-2025)

3.1.2 Global Oncolytic Virus Drug Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Oncolytic Virus Drug Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oncolytic Virus Drug Treatment Revenue

3.4 Global Oncolytic Virus Drug Treatment Market Concentration Ratio

3.4.1 Global Oncolytic Virus Drug Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Drug Treatment Revenue in 2024

3.5 Global Key Players of Oncolytic Virus Drug Treatment Head office and Area Served

3.6 Global Key Players of Oncolytic Virus Drug Treatment, Product and Application

3.7 Global Key Players of Oncolytic Virus Drug Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oncolytic Virus Drug Treatment Breakdown Data by Type

4.1 Global Oncolytic Virus Drug Treatment Historic Market Size by Type (2020-2025)

4.2 Global Oncolytic Virus Drug Treatment Forecasted Market Size by Type (2026-2031)

5 Oncolytic Virus Drug Treatment Breakdown Data by Application

5.1 Global Oncolytic Virus Drug Treatment Historic Market Size by Application (2020-2025)

5.2 Global Oncolytic Virus Drug Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oncolytic Virus Drug Treatment Market Size (2020-2031)

6.2 North America Oncolytic Virus Drug Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oncolytic Virus Drug Treatment Market Size by Country (2020-2025)

6.4 North America Oncolytic Virus Drug Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oncolytic Virus Drug Treatment Market Size (2020-2031)

7.2 Europe Oncolytic Virus Drug Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oncolytic Virus Drug Treatment Market Size by Country (2020-2025)

7.4 Europe Oncolytic Virus Drug Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oncolytic Virus Drug Treatment Market Size (2020-2031)

8.2 Asia-Pacific Oncolytic Virus Drug Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oncolytic Virus Drug Treatment Market Size (2020-2031)

9.2 Latin America Oncolytic Virus Drug Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oncolytic Virus Drug Treatment Market Size by Country (2020-2025)

9.4 Latin America Oncolytic Virus Drug Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oncolytic Virus Drug Treatment Market Size (2020-2031)

10.2 Middle East & Africa Oncolytic Virus Drug Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Details

11.1.2 Amgen Business Overview

11.1.3 Amgen Oncolytic Virus Drug Treatment Introduction

11.1.4 Amgen Revenue in Oncolytic Virus Drug Treatment Business (2020-2025)

11.1.5 Amgen Recent Development

11.2 Oncolytics Biotech

11.2.1 Oncolytics Biotech Company Details

11.2.2 Oncolytics Biotech Business Overview

11.2.3 Oncolytics Biotech Oncolytic Virus Drug Treatment Introduction

11.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Drug Treatment Business (2020-2025)

11.2.5 Oncolytics Biotech Recent Development

11.3 Viralytics

11.3.1 Viralytics Company Details

11.3.2 Viralytics Business Overview

11.3.3 Viralytics Oncolytic Virus Drug Treatment Introduction

11.3.4 Viralytics Revenue in Oncolytic Virus Drug Treatment Business (2020-2025)

11.3.5 Viralytics Recent Development

11.4 Transgene SA

11.4.1 Transgene SA Company Details

11.4.2 Transgene SA Business Overview

11.4.3 Transgene SA Oncolytic Virus Drug Treatment Introduction

11.4.4 Transgene SA Revenue in Oncolytic Virus Drug Treatment Business (2020-2025)

11.4.5 Transgene SA Recent Development

11.5 Oncolys BioPharma

11.5.1 Oncolys BioPharma Company Details

11.5.2 Oncolys BioPharma Business Overview

11.5.3 Oncolys BioPharma Oncolytic Virus Drug Treatment Introduction

11.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Drug Treatment Business (2020-2025)

11.5.5 Oncolys BioPharma Recent Development

11.6 Targovax

11.6.1 Targovax Company Details

11.6.2 Targovax Business Overview

11.6.3 Targovax Oncolytic Virus Drug Treatment Introduction

11.6.4 Targovax Revenue in Oncolytic Virus Drug Treatment Business (2020-2025)

11.6.5 Targovax Recent Development

11.7 PsiOxus Therapeutics

11.7.1 PsiOxus Therapeutics Company Details

11.7.2 PsiOxus Therapeutics Business Overview

11.7.3 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Introduction

11.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2020-2025)

11.7.5 PsiOxus Therapeutics Recent Development

11.8 SillaJen Biotherapeutics

11.8.1 SillaJen Biotherapeutics Company Details

11.8.2 SillaJen Biotherapeutics Business Overview

11.8.3 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Introduction

11.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2020-2025)

11.8.5 SillaJen Biotherapeutics Recent Development

11.9 Sorrento Therapeutics

11.9.1 Sorrento Therapeutics Company Details

11.9.2 Sorrento Therapeutics Business Overview

11.9.3 Sorrento Therapeutics Oncolytic Virus Drug Treatment Introduction

11.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2020-2025)

11.9.5 Sorrento Therapeutics Recent Development

11.10 Lokon Pharma

11.10.1 Lokon Pharma Company Details

11.10.2 Lokon Pharma Business Overview

11.10.3 Lokon Pharma Oncolytic Virus Drug Treatment Introduction

11.10.4 Lokon Pharma Revenue in Oncolytic Virus Drug Treatment Business (2020-2025)

11.10.5 Lokon Pharma Recent Development

11.11 Genelux Corporation

11.11.1 Genelux Corporation Company Details

11.11.2 Genelux Corporation Business Overview

11.11.3 Genelux Corporation Oncolytic Virus Drug Treatment Introduction

11.11.4 Genelux Corporation Revenue in Oncolytic Virus Drug Treatment Business (2020-2025)

11.11.5 Genelux Corporation Recent Development

11.12 Vyriad

11.12.1 Vyriad Company Details

11.12.2 Vyriad Business Overview

11.12.3 Vyriad Oncolytic Virus Drug Treatment Introduction

11.12.4 Vyriad Revenue in Oncolytic Virus Drug Treatment Business (2020-2025)

11.12.5 Vyriad Recent Development

11.13 TILT Biotherapeutics

11.13.1 TILT Biotherapeutics Company Details

11.13.2 TILT Biotherapeutics Business Overview

11.13.3 TILT Biotherapeutics Oncolytic Virus Drug Treatment Introduction

11.13.4 TILT Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2020-2025)

11.13.5 TILT Biotherapeutics Recent Development

11.14 Cold Genesys

11.14.1 Cold Genesys Company Details

11.14.2 Cold Genesys Business Overview

11.14.3 Cold Genesys Oncolytic Virus Drug Treatment Introduction

11.14.4 Cold Genesys Revenue in Oncolytic Virus Drug Treatment Business (2020-2025)

11.14.5 Cold Genesys Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Amgen Inc

Oncolytics Biotech

Viralytics

Transgene SA

Oncolys BioPharma

Targovax

PsiOxus Therapeutics

SillaJen Biotherapeutics

Sorrento Therapeutics

Lokon Pharma

Genelux Corporation

Vyriad

TILT Biotherapeutics

Cold Genesys

List of Tables

Table 1. Global Oncolytic Virus Drug Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Phase 1

Table 3. Key Players of Phase 2

Table 4. Key Players of Others

Table 5. Global Oncolytic Virus Drug Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Oncolytic Virus Drug Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Oncolytic Virus Drug Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Oncolytic Virus Drug Treatment Market Share by Region (2020-2025)

Table 9. Global Oncolytic Virus Drug Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Oncolytic Virus Drug Treatment Market Share by Region (2026-2031)

Table 11. Oncolytic Virus Drug Treatment Market Trends

Table 12. Oncolytic Virus Drug Treatment Market Drivers

Table 13. Oncolytic Virus Drug Treatment Market Challenges

Table 14. Oncolytic Virus Drug Treatment Market Restraints

Table 15. Global Oncolytic Virus Drug Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Oncolytic Virus Drug Treatment Market Share by Players (2020-2025)

Table 17. Global Top Oncolytic Virus Drug Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Drug Treatment as of 2024)

Table 18. Ranking of Global Top Oncolytic Virus Drug Treatment Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Oncolytic Virus Drug Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Oncolytic Virus Drug Treatment, Headquarters and Area Served

Table 21. Global Key Players of Oncolytic Virus Drug Treatment, Product and Application

Table 22. Global Key Players of Oncolytic Virus Drug Treatment, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Oncolytic Virus Drug Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Oncolytic Virus Drug Treatment Revenue Market Share by Type (2020-2025)

Table 26. Global Oncolytic Virus Drug Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Oncolytic Virus Drug Treatment Revenue Market Share by Type (2026-2031)

Table 28. Global Oncolytic Virus Drug Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Oncolytic Virus Drug Treatment Revenue Market Share by Application (2020-2025)

Table 30. Global Oncolytic Virus Drug Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Oncolytic Virus Drug Treatment Revenue Market Share by Application (2026-2031)

Table 32. North America Oncolytic Virus Drug Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Oncolytic Virus Drug Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Oncolytic Virus Drug Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Oncolytic Virus Drug Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Oncolytic Virus Drug Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Oncolytic Virus Drug Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Oncolytic Virus Drug Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Oncolytic Virus Drug Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Oncolytic Virus Drug Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Oncolytic Virus Drug Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Oncolytic Virus Drug Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 47. Amgen Company Details

Table 48. Amgen Business Overview

Table 49. Amgen Oncolytic Virus Drug Treatment Product

Table 50. Amgen Revenue in Oncolytic Virus Drug Treatment Business (2020-2025) & (US$ Million)

Table 51. Amgen Recent Development

Table 52. Oncolytics Biotech Company Details

Table 53. Oncolytics Biotech Business Overview

Table 54. Oncolytics Biotech Oncolytic Virus Drug Treatment Product

Table 55. Oncolytics Biotech Revenue in Oncolytic Virus Drug Treatment Business (2020-2025) & (US$ Million)

Table 56. Oncolytics Biotech Recent Development

Table 57. Viralytics Company Details

Table 58. Viralytics Business Overview

Table 59. Viralytics Oncolytic Virus Drug Treatment Product

Table 60. Viralytics Revenue in Oncolytic Virus Drug Treatment Business (2020-2025) & (US$ Million)

Table 61. Viralytics Recent Development

Table 62. Transgene SA Company Details

Table 63. Transgene SA Business Overview

Table 64. Transgene SA Oncolytic Virus Drug Treatment Product

Table 65. Transgene SA Revenue in Oncolytic Virus Drug Treatment Business (2020-2025) & (US$ Million)

Table 66. Transgene SA Recent Development

Table 67. Oncolys BioPharma Company Details

Table 68. Oncolys BioPharma Business Overview

Table 69. Oncolys BioPharma Oncolytic Virus Drug Treatment Product

Table 70. Oncolys BioPharma Revenue in Oncolytic Virus Drug Treatment Business (2020-2025) & (US$ Million)

Table 71. Oncolys BioPharma Recent Development

Table 72. Targovax Company Details

Table 73. Targovax Business Overview

Table 74. Targovax Oncolytic Virus Drug Treatment Product

Table 75. Targovax Revenue in Oncolytic Virus Drug Treatment Business (2020-2025) & (US$ Million)

Table 76. Targovax Recent Development

Table 77. PsiOxus Therapeutics Company Details

Table 78. PsiOxus Therapeutics Business Overview

Table 79. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Product

Table 80. PsiOxus Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2020-2025) & (US$ Million)

Table 81. PsiOxus Therapeutics Recent Development

Table 82. SillaJen Biotherapeutics Company Details

Table 83. SillaJen Biotherapeutics Business Overview

Table 84. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Product

Table 85. SillaJen Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2020-2025) & (US$ Million)

Table 86. SillaJen Biotherapeutics Recent Development

Table 87. Sorrento Therapeutics Company Details

Table 88. Sorrento Therapeutics Business Overview

Table 89. Sorrento Therapeutics Oncolytic Virus Drug Treatment Product

Table 90. Sorrento Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2020-2025) & (US$ Million)

Table 91. Sorrento Therapeutics Recent Development

Table 92. Lokon Pharma Company Details

Table 93. Lokon Pharma Business Overview

Table 94. Lokon Pharma Oncolytic Virus Drug Treatment Product

Table 95. Lokon Pharma Revenue in Oncolytic Virus Drug Treatment Business (2020-2025) & (US$ Million)

Table 96. Lokon Pharma Recent Development

Table 97. Genelux Corporation Company Details

Table 98. Genelux Corporation Business Overview

Table 99. Genelux Corporation Oncolytic Virus Drug Treatment Product

Table 100. Genelux Corporation Revenue in Oncolytic Virus Drug Treatment Business (2020-2025) & (US$ Million)

Table 101. Genelux Corporation Recent Development

Table 102. Vyriad Company Details

Table 103. Vyriad Business Overview

Table 104. Vyriad Oncolytic Virus Drug Treatment Product

Table 105. Vyriad Revenue in Oncolytic Virus Drug Treatment Business (2020-2025) & (US$ Million)

Table 106. Vyriad Recent Development

Table 107. TILT Biotherapeutics Company Details

Table 108. TILT Biotherapeutics Business Overview

Table 109. TILT Biotherapeutics Oncolytic Virus Drug Treatment Product

Table 110. TILT Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2020-2025) & (US$ Million)

Table 111. TILT Biotherapeutics Recent Development

Table 112. Cold Genesys Company Details

Table 113. Cold Genesys Business Overview

Table 114. Cold Genesys Oncolytic Virus Drug Treatment Product

Table 115. Cold Genesys Revenue in Oncolytic Virus Drug Treatment Business (2020-2025) & (US$ Million)

Table 116. Cold Genesys Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

Table 120. Authors List of This Report

List of Figures

Figure 1. Oncolytic Virus Drug Treatment Picture

Figure 2. Global Oncolytic Virus Drug Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oncolytic Virus Drug Treatment Market Share by Type: 2024 VS 2031

Figure 4. Phase 1 Features

Figure 5. Phase 2 Features

Figure 6. Others Features

Figure 7. Global Oncolytic Virus Drug Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Oncolytic Virus Drug Treatment Market Share by Application: 2024 VS 2031

Figure 9. Melanoma Case Studies

Figure 10. Prostate Cancer Case Studies

Figure 11. Breast Cancer Case Studies

Figure 12. Ovarian Cancer Case Studies

Figure 13. Others Case Studies

Figure 14. Oncolytic Virus Drug Treatment Report Years Considered

Figure 15. Global Oncolytic Virus Drug Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Oncolytic Virus Drug Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Oncolytic Virus Drug Treatment Market Share by Region: 2024 VS 2031

Figure 18. Global Oncolytic Virus Drug Treatment Market Share by Players in 2024

Figure 19. Global Top Oncolytic Virus Drug Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Drug Treatment as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Oncolytic Virus Drug Treatment Revenue in 2024

Figure 21. North America Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Oncolytic Virus Drug Treatment Market Share by Country (2020-2031)

Figure 23. United States Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Oncolytic Virus Drug Treatment Market Share by Country (2020-2031)

Figure 27. Germany Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Oncolytic Virus Drug Treatment Market Share by Region (2020-2031)

Figure 35. China Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Oncolytic Virus Drug Treatment Market Share by Country (2020-2031)

Figure 43. Mexico Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Oncolytic Virus Drug Treatment Market Share by Country (2020-2031)

Figure 47. Turkey Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Oncolytic Virus Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Amgen Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2020-2025)

Figure 51. Oncolytics Biotech Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2020-2025)

Figure 52. Viralytics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2020-2025)

Figure 53. Transgene SA Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2020-2025)

Figure 54. Oncolys BioPharma Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2020-2025)

Figure 55. Targovax Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2020-2025)

Figure 56. PsiOxus Therapeutics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2020-2025)

Figure 57. SillaJen Biotherapeutics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2020-2025)

Figure 58. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2020-2025)

Figure 59. Lokon Pharma Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2020-2025)

Figure 60. Genelux Corporation Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2020-2025)

Figure 61. Vyriad Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2020-2025)

Figure 62. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2020-2025)

Figure 63. Cold Genesys Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Still s Disease Treatment Market Research Report 2025

Global Pediatric Oncology Treatment Market Research Report 2025

Global Gynecological Cancers Drug Market Research Report 2025

Global Combination Therapy Drug Market Research Report 2025

Global Drug Safety and Pharmacovigilance Service Market Research Report 2025

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Global Diagnostic Guidewire Market Research Report 2024

Global Anti Infectives Market Research Report 2025

Global Pharmaceutical Validation Services Market Research Report 2025

Global Critical Care Therapeutics Market Research Report 2025

Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global PD 1 and PD L1 Inhibitor Market Research Report 2025

Global Pharma Contract Service Market Research Report 2025

Global Pharmerging Market Research Report 2025

Global Drugs of Abuse Testing Market Research Report 2024

Global Reproductive and Fertility Diagnosis Market Research Report 2025

Global Weekly Pill Organizer Market Research Report 2025

Global Pharmaceutical Asset Management Market Research Report 2025

Global Radiotherapy Device Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions